[Federal Register Volume 73, Number 36 (Friday, February 22, 2008)]
[Notices]
[Page 9807]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-824]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:
    Times and Dates:
    8 a.m.-5 p.m., February 20, 2008.
    8 a.m.-3:30 p.m., February 21, 2008.
    Place: Centers for Disease Control and Prevention, 1600 Clifton 
Road, NE., Tom Harkin Global Communications Center, Building 19, Room 
232, Auditorium B, Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This Committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the standards 
under which clinical laboratories are regulated; the impact on medical 
and laboratory practice of proposed revisions to the standards; and the 
modification of the standards to accommodate technological advances.
    Matters To Be Discussed: The agenda will include updates from the 
CDC, the Centers for Medicare & Medicaid Services, and the Food and 
Drug Administration; and presentations and discussion addressing ``20 
Years of CLIA: Needs for Quality Then vs. Now;'' evidence gathered 
since CLIA implementation demonstrating the impact of standards/
accreditation on laboratory quality; perspectives on Quality Management 
System implementation; and laboratory biosafety. Agenda items are 
subject to change as priorities dictate.
    Due to administrative issues that had to be resolved, the Federal 
Register notice is being published less than fifteen days before the 
date of the meeting.
    Contact Person for More Information: Nancy Anderson, Chief, 
Laboratory Practice Standards Branch, Division of Laboratory Systems, 
National Center for Preparedness, Detection, and Control of Infectious 
Diseases, Coordinating Center for Infectious Diseases, CDC, 1600 
Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30333; telephone 
(404) 718-1025; fax (404) 718-1085; or via e-mail at 
<a href="/cdn-cgi/l/email-protection#afe1cec1ccd681eec1cbcadddcc0c1efcccbcc81c7c7dc81c8c0d9"><span class="__cf_email__" data-cfemail="440a252a273d6a052a202136372b2a042720276a2c2c376a232b32">[email protected]</span></a>.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: February 19, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 08-824 Filed 2-20-08; 10:32 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>